Swiss person dies after COVID-19 vaccination
https://www.channelnewsasia.com/news/world/covid-19-vaccine-pfizer-swiss-dies-coronavirus-13866818

Swiss person dies after COVID-19 vaccination
https://www.channelnewsasia.com/news/world/covid-19-vaccine-pfizer-swiss-dies-coronavirus-13866818

Vaccinated U.S. nurse contracts COVID-19
https://www.reuters.com/article/health-coronavirus-usa-vaccine/california-nurse-tests-positive-over-a-week-after-receiving-pfizer-covid-19-vaccine-abc-idINKBN2940QJ

Vaccinated U.S. nurse contracts COVID-19
https://www.reuters.com/article/health-coronavirus-usa-vaccine/california-nurse-tests-positive-over-a-week-after-receiving-pfizer-covid-19-vaccine-abc-idINKBN2940QJ

New Covid-19 strain identified in Sabah, says Health Ministry
https://www.thestar.com.my/news/nation/2020/12/23/new-covid-19-strain-identified-in-sabah-says-health-ministry

New Covid-19 strain identified in Sabah, says Health Ministry
https://www.thestar.com.my/news/nation/2020/12/23/new-covid-19-strain-identified-in-sabah-says-health-ministry

https://www.theedgemarkets.com/article/gamuda-aims-rm10b-new-order-book
Gamuda Bhd is aiming for new order book of about RM10 billion for 2021, involving a combination of international and domestic infrastructure projects, according to group managing director Datuk Lin Yun Ling.

https://www.theedgemarkets.com/article/gamuda-aims-rm10b-new-order-book
Gamuda Bhd is aiming for new order book of about RM10 billion for 2021, involving a combination of international and domestic infrastructure projects, according to group managing director Datuk Lin Yun Ling.

https://www.theedgemarkets.com/article/asia-poly-buys-30-stake-acrylic-manufacturer-gb-plas-rm15m

"We see a rising demand for extruded acrylic and plastic sheets in Asia, the US and European markets. In fact, we are anticipating a large long-term contract from a US customer which is currently in its advanced stage of discussion."

"Furthermore, given that Asia Poly's production lines are currently running at full capacity, the acquisition shall provide an immediate expansion opportunity as GB Plas' plant is currently running at a utilisation rate of between 50% and 60%. This boosts our initial plan of doubling up our production capacity to 1,600 tonnes per month by September 2021," Asia Poly executive chairman Datuk Yeo Boon Leong said in a statement today.

https://www.thestar.com.my/business/business-news/2020/11/06/winners-and-losers-from-budget-2021

Builders

Builders including Gamuda Bhd and IJM Corp Bhd stand to gain. The government will go ahead in implementing transport infrastructure projects and will allocate RM15bil ringgit to fund the Pan Borneo Highway, Gemas-Johor Bahru electrified double-tracking rail project and phase one of the Klang Valley double tracking project. The Rapid Transit System Link from Johor Bahru to Woodlands, Singapore and the MRT3 in Klang Valley will also continue. The government will also continue with the High-Speed Rail Project with Singapore because of its multiplier effect on the economy.

https://www.thestar.com.my/business/business-news/2020/11/06/winners-and-losers-from-budget-2021
Builders

Builders including Gamuda Bhd and IJM Corp Bhd stand to gain. The government will go ahead in implementing transport infrastructure projects and will allocate RM15bil ringgit to fund the Pan Borneo Highway, Gemas-Johor Bahru electrified double-tracking rail project and phase one of the Klang Valley double tracking project. The Rapid Transit System Link from Johor Bahru to Woodlands, Singapore and the MRT3 in Klang Valley will also continue. The government will also continue with the High-Speed Rail Project with Singapore because of its multiplier effect on the economy.

GAMUDA - More Surprises Ahead ! Expected to win more mega projects !
https://youtu.be/AqitEPsOUxs

GAMUDA - More Surprises Ahead ! Expected to win more mega projects !
https://youtu.be/AqitEPsOUxs

Most undervalued glove stock - SRI TRANG AGRO (SGX:NC2) net profit jumped 333.5% YoY
https://youtu.be/EXkImhhjM8Q

Top Glove eyes Hong Kong listing
https://www.theedgemarkets.com/article/top-glove-eyes-hong-kong-listing

GAMUDA - More Surprises Ahead ! Expected to win more mega projects !
https://klse.i3investor.com/blogs/Bursa_Malaysia/2020-09-17-story-h1513526819-GAMUDA_More_Surprises_Ahead_Expected_to_win_more_mega_projects.jsp

GAMUDA - More Surprises Ahead ! Expected to win more mega projects !
https://klse.i3investor.com/blogs/Bursa_Malaysia/2020-09-17-story-h1513526819-GAMUDA_More_Surprises_Ahead_Expected_to_win_more_mega_projects.jsp

AstraZeneca pauses Covid-19 vaccine trial after unexplained illness
(Sept 9): AstraZeneca Plc stopped giving shots of its experimental coronavirus vaccine after a person participating in one of the company’s studies got sick, a potential adverse reaction that could delay or derail efforts to speed an immunization against Covid-19 for the world.

AstraZeneca pauses Covid-19 vaccine trial after unexplained illness
(Sept 9): AstraZeneca Plc stopped giving shots of its experimental coronavirus vaccine after a person participating in one of the company’s studies got sick, a potential adverse reaction that could delay or derail efforts to speed an immunization against Covid-19 for the world.

AstraZeneca pauses Covid-19 vaccine trial after unexplained illness
(Sept 9): AstraZeneca Plc stopped giving shots of its experimental coronavirus vaccine after a person participating in one of the company’s studies got sick, a potential adverse reaction that could delay or derail efforts to speed an immunization against Covid-19 for the world.

AstraZeneca pauses Covid-19 vaccine trial after unexplained illness
(Sept 9): AstraZeneca Plc stopped giving shots of its experimental coronavirus vaccine after a person participating in one of the company’s studies got sick, a potential adverse reaction that could delay or derail efforts to speed an immunization against Covid-19 for the world.

AstraZeneca pauses Covid-19 vaccine trial after unexplained illness
(Sept 9): AstraZeneca Plc stopped giving shots of its experimental coronavirus vaccine after a person participating in one of the company’s studies got sick, a potential adverse reaction that could delay or derail efforts to speed an immunization against Covid-19 for the world.

AstraZeneca pauses Covid-19 vaccine trial after unexplained illness
(Sept 9): AstraZeneca Plc stopped giving shots of its experimental coronavirus vaccine after a person participating in one of the company’s studies got sick, a potential adverse reaction that could delay or derail efforts to speed an immunization against Covid-19 for the world.

AstraZeneca pauses Covid-19 vaccine trial after unexplained illness
(Sept 9): AstraZeneca Plc stopped giving shots of its experimental coronavirus vaccine after a person participating in one of the company’s studies got sick, a potential adverse reaction that could delay or derail efforts to speed an immunization against Covid-19 for the world.

https://www.theedgemarkets.com/article/rhb-research-raises-target-price-comfort-gloves-rm570-expects-stronger-results-3qfy21

The Most Undervalued GLOVE counter !!!
https://www.youtube.com/watch?v=wD8tHOb_mAA&t=2s

The Most Undervalued GLOVE counter !!!
https://www.youtube.com/watch?v=wD8tHOb_mAA&t=2s

Has anyone considered to invest in Pentamaster International Ltd listed on Hong Kong ?
Its valuation seems to be cheaper than Pentamaster listed on Bursa.

Hi DK , please add me to the group.
Thanks.

Thanks, please help to subscribe to the Youtube channel, thanks !!!

Legendary value stock investor, Fong Siling Coldeye (冷眼)

https://klse.i3investor.com/blogs/FongSilingColdeye/2020-05-10-story-h1506972670.jsp

Legendary value stock investor, Fong Siling Coldeye (冷眼)

https://klse.i3investor.com/blogs/FongSilingColdeye/2020-05-10-story-h1506972670.jsp

Legendary value stock investor, Fong Siling Coldeye (冷眼)

https://klse.i3investor.com/blogs/FongSilingColdeye/2020-05-10-story-h1506972670.jsp